NT-proBNP & ACE-2 levels for predicting cardiac events after emergency orthopaedic surgery .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery
Am J Cardiol. 2012 May 1;109(9):1365-73. doi: 10.1016/j.amjcard.2011.12.032. Epub 2012 Feb 28.187 patients (>60 years old) undergoing emergency orthopaedic surgery and participating in a randomized controlled trial were monitored in this observational study. The purpose of this analysis was to determine whether both pre- and postoperative levels of the inactive form of brain natriuretic peptide (N-terminal pro-BNP) and angiotensin-converting enzyme 2 (ACE-2) significantly predict the incidence of cardiac events in hospital and at 1 year. Results indicated that preoperative N-terminal pro-BNP levels of 741 pg/mL or greater, as well as postoperative NT-proBNP levels of 1,064 pg/mL or greater, significantly predicted cardiac events in hospital and at 1 year. However, the same could not be said for either pre- or postoperative angiotensin-converting enzyme 2 (ACE-2) levels.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics